Objective The objective of the present review is to provide a brief overview of research on
decision making and cancer with a specific focus on the role of emotions. Method Thirty-nine …

Background The demand for clinical trial participants is today one of the highest it has ever
been and continues to increase. At the same time, subject recruitment continues to be …

Objective To describe patient perspectives on recruitment and retention in clinical trials.
Study Design and Setting Systematic review of qualitative studies that reported the …

Aims and objectives To examine cancer patients' perceptions of factors that may influence
their decisions on participating in phase I–III clinical drug trials. Background The number of …

Background Taking part in a cancer clinical trial often represents a source of psychological
distress and emotional activation among patients and their caregivers. Nowadays, social …

Purpose Although cancer clinical trials (CT) offer opportunities for novel treatments that may
lead to improved outcomes, adolescents and young adults (AYA) are less likely to …

Patient participation in cancer clinical trials is low. Little is known about attitudinal barriers to
participation, particularly among patients who may be offered a trial during an imminent …

Background Being diagnosed with cancer is an existential challenge and involves difficult
treatment decisions, including treatment in clinical trials. Therapy for advanced cancer is …

Radiation oncology clinical trials lack full representation of the ethnic and racial diversity
present in the general United States and in the cancer patient population. There are low …

Objectives Bench to bedside translation of groundbreaking treatments like chimeric antigen
receptor T (CAR-T) cell therapy depends on patient participation in early phase trials …